Released Sep 7, 2018, after the close
10-Q filed Sep 10, 2018, 72 days after period end · 0001213900-18-012298
Q2 2018 · 10-Q
Revenue—
Net Income-$1.79M-$1.79M N/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.50-$0.50 N/M vs Q2 2017N/M vs Q1 2018
Operating Income-$1,741,467N/M
Operating Cash Flowderived-$188,940—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2018 | Q2 2017 |
|---|---|---|
| Net Income | -$1.79M | -$264.27K |
| EPS Diluted | -$0.50 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Azora Therapeutics, Inc. (DE) · CIK 1513525 · Engraved from SEC EDGAR